Will Novo Nordisk Overtake Eli Lilly as the Most Valuable Healthcare Stock?The Motley Fool • 03/20/24
A new study cites the health risks of intermittent fasting. Could it lift Ozempic sales?Market Watch • 03/19/24
Is Madrigal Pharmaceuticals Stock a Better Buy Than Eli Lilly and Novo Nordisk After Its Huge FDA Win?The Motley Fool • 03/19/24
The Novo Nordisk Foundation chooses Eviden to build “Gefion” in Denmark, one of the world's most powerful AI supercomputersGlobeNewsWire • 03/19/24
Novo Nordisk (NVO) Rises Yet Lags Behind Market: Some Facts Worth KnowingZacks Investment Research • 03/18/24
Weight loss drug Wegovy is now approved for heart health — but that won't mean broad insurance coverage just yetCNBC • 03/18/24
Novo Nordisk Isn't in The "Magnificent Seven," but Here's Why I Think It Should BeThe Motley Fool • 03/17/24
Weight loss drug Wegovy is now approved for heart health - but that won't mean broad insurance coverage just yetCNBC • 03/16/24
All You Need to Know About Novo Nordisk (NVO) Rating Upgrade to BuyZacks Investment Research • 03/12/24
1 Big New Reason to Buy Novo Nordisk Stock Hand Over Fist Right This InstantThe Motley Fool • 03/12/24